 , Anti-Infective Agents , Anti-Retroviral Agents , Antiinfectives for Systemic Use , Antiviral Agents , Antivirals for Systemic Use , Antivirals used in combination for the treatment of HIV infections , BSEP/ABCB11 Substrates , Central Nervous System Depressants , Cycloparaffins , Cytochrome P-450 CYP1A2 Inhibitors , Cytochrome P-450 CYP1A2 Inhibitors (strength unknown) , Cytochrome P-450 CYP1A2 Substrates , Cytochrome P-450 CYP2B6 Inducers , Cytochrome P-450 CYP2B6 Inducers (strength unknown) , Cytochrome P-450 CYP2B6 Substrates , Cytochrome P-450 CYP2C19 Inducers , Cytochrome P-450 CYP2C19 Inducers (strength unknown) , Cytochrome P-450 CYP2C19 Inhibitors , Cytochrome P-450 CYP2C19 Inhibitors (moderate) , Cytochrome P-450 CYP2C8 Inhibitors , Cytochrome P-450 CYP2C8 Inhibitors (moderate) , Cytochrome P-450 CYP2C9 Inhibitors , Cytochrome P-450 CYP2C9 Inhibitors (moderate) , Cytochrome P-450 CYP2D6 Inhibitors , Cytochrome P-450 CYP2D6 Inhibitors (strength unknown) , Cytochrome P-450 CYP3A Inducers , Cytochrome P-450 CYP3A Inhibitors , Cytochrome P-450 CYP3A Substrates , Cytochrome P-450 CYP3A4 Inducers , Cytochrome P-450 CYP3A4 Inducers (moderate) , Cytochrome P-450 CYP3A4 Inhibitors , Cytochrome P-450 CYP3A4 Inhibitors (strong) , Cytochrome P-450 CYP3A4 Substrates , Cytochrome P-450 CYP3A5 Inducers , Cytochrome P-450 CYP3A5 Inducers (moderate) , Cytochrome P-450 CYP3A7 Inducers , Cytochrome P-450 CYP3A7 Inducers (moderate) , Cytochrome P-450 Enzyme Inducers , Cytochrome P-450 Enzyme Inhibitors , Cytochrome P-450 Substrates , Direct Acting Antivirals , Enzyme Inhibitors , Heterocyclic Compounds, Fused-Ring , Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor , Hydrocarbons, Acyclic , Inducers of Drug Clearance , Moderate Risk QTc-Prolonging Agents , Non-Nucleoside Reverse Transcriptase Inhibitors , Nonnucleoside Reverse Transcriptase Inhibitors , Nucleic Acid Synthesis Inhibitors , OCT1 inhibitors , Oxazines , QTc Prolonging Agents , Reverse Transcriptase Inhibitors , UGT1A1 Inducers